The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])

Clinical trial NCT00518102 · COMPLETED

Trial details

NCT number: NCT00518102
Sponsor: Ethicon, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus

Start date: 2003-01-01
Primary completion: 2005-05-01
Enrollment: 4431

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.